Puma Biotechnology (PBYI) Finished Goods (2020 - 2026)

Puma Biotechnology has reported Finished Goods for 7 years, with the latest figure at $767000.0 in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods rose 36.72% year-over-year to $767000.0; the trailing twelve-month figure through Mar 2026 stood at $767000.0 (up 36.72% YoY), and the FY2025 full-year result was $960000.0, up 22.61% from the prior year.
• Finished Goods for Q1 2026 stood at $767000.0, down from $960000.0 in the prior quarter.
• The five-year high for Finished Goods was $1.6 million in Q1 2022, with the low at $186000.0 in Q4 2022.
• Historically, Finished Goods has averaged $696000.0 across 5 years, with a median of $642000.0 in 2022.
• Annual changes were most pronounced in 2022 — Finished Goods plunged 83.9% — and 2023, when it jumped 204.84%.
• Puma Biotechnology's Finished Goods stood at $186000.0 in 2022, then jumped by 204.84% to $567000.0 in 2023, then soared by 38.1% to $783000.0 in 2024, then increased by 22.61% to $960000.0 in 2025, then decreased by 20.1% to $767000.0 in 2026.
• The last three Finished Goods figures came in at $767000.0 (Q1 2026), $960000.0 (Q4 2025), and $439000.0 (Q3 2025), per Business Quant data.